Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olympus
Devices
Olympus pushes deeper into oncology with $270M BioProtect deal
Olympus is moving deeper into prostate cancer care with the acquisition of BioProtect and its radiation-protection spacer technology.
Ayla Ellison
May 26, 2026 3:57pm
Olympus-backed Swan EndoSurgical taps Stryker vet for CEO
Dec 3, 2025 9:20am
Olympus updates corrective action related to 2023 lung scope recall
Nov 4, 2025 8:00am
Olympus launches AI for spotting polyps in colonoscopy
Sep 30, 2025 11:30am
Olympus forms GI robotics startup with Revival Healthcare
Jul 25, 2025 11:50am
FDA moves to block Olympus endoscope imports
Jun 25, 2025 12:05pm
